For: | Wang D, Wang YS, Zhao HM, Lu P, Li M, Li W, Cui HT, Zhang ZY, Lv SQ. Plantamajoside improves type 2 diabetes mellitus pancreatic β-cell damage by inhibiting endoplasmic reticulum stress through Dnajc1 up-regulation. World J Diabetes 2025; 16(2): 99053 [PMID: 39959264 DOI: 10.4239/wjd.v16.i2.99053] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v16/i2/99053.htm |
Number | Citing Articles |
1 |
Na Liu, Wei-Tao Yan, Kun Xiong. Plantamajoside: A potentially novel botanical agent for diabetes mellitus management. World Journal of Diabetes 2025; 16(5): 104311 doi: 10.4239/wjd.v16.i5.104311
|
2 |
Md Abdul Alim Al-Bari, Fabian Davamani, Payal Bhatnagar, Nabil Eid. Plantamajoside mitigates endoplasmic reticulum stress-mediated pancreatic β-cell apoptosis in type 2 diabetes <i>via</i> DNAJC1 upregulation. World Journal of Diabetes 2025; 16(4): 104241 doi: 10.4239/wjd.v16.i4.104241
|
3 |
Hongmin Zhao, Renlin Li, Xuan Guo, Jingrui Kang, Huajun Li, Xiaoyun Wang, Yuansong Wang, Huantian Cui, Shuquan Lv, Weibo Wen, Zhongyong Zhang, Kai Huang. Mechanism of Plantamajoside in inhibiting ferroptosis of pancreatic β cells and treatment of T2DM via activation of the xCT/GPX4 pathway. PLOS One 2025; 20(6): e0325674 doi: 10.1371/journal.pone.0325674
|